Skinbiotherapeutics PLC

SkinBioTherapeutics’ 23% stake by Rock Nominees triggers a market suspension; learn how the move could reshape its skin‑health innovations and investor outlook.

Skinbiotherapeutics PLC unveils new audit chair and external probe to boost governance and financial transparency amid market volatility.

SkinBioTherapeutics PLC is a pioneering life science company that is revolutionizing skin healthcare through its innovative platform and commitment to addressing key skin health issues.